Annual report [Section 13 and 15(d), not S-K Item 405]

NET LOSS PER SHARE - Outstanding potentially dilutive common shares (Details)

v3.25.1
NET LOSS PER SHARE - Outstanding potentially dilutive common shares (Details) - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 58,554,887 15,136,252
Pre- funded warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of warrants to purchase common shares 2,162,013 594,725
Employee Stock Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 3,574,453 967,262
Warrants.    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 54,979,373 13,001,262
Series 2 Convertible Preferred Share Member    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive   1,166,667
Deferred Share Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 1,061 1,061